APOE Allele Frequency in Southern Greece: Exploring the Role of Geographical Gradient in the Greek Population
Authors:
- Vasiliki PapastefanopoulouVPVasiliki Papastefanopoulou
- Evangelia StanitsaEvangelia Stanitsa
- Christos KorosCKChristos Koros
- Aimilios SimoudisASAimilios Simoudis
- Chryseis Florou-HatziyiannidouCFChryseis Florou-Hatziyiannidou
- Ion BeratisIBIon Beratis
- Roubina AntonelouRARoubina Antonelou
- Nikolaos AndronasNANikolaos Andronas
- Panagiota VoskouPanagiota Voskou
- Efthalia AngelopoulouEfthalia Angelopoulou
- John D. PapatriantafyllouJPJohn D. Papatriantafyllou
- Leonidas StefanisLSLeonidas Stefanis
Open Access
- 20 December 2022
- journal article
- research article
- Published by MDPI AG in Geriatrics
- Vol. 8 (1) , 1
Abstract
Background: the apolipoprotein e4 allele (APOE4) constitutes an established genetic risk factor for Alzheimer’s Disease Dementia (ADD). We aimed to explore the frequency of the APOE isoforms in the Greek population of Southern Greece. Methods: peripheral blood from 175 Greek AD patients, 113 with mild cognitive impairment (MCI), and 75 healthy individuals. DNA isolation was performed with a High Pure PCR Template Kit (Roche), followed by amplification with a real-time qPCR kit (TIB MolBiol) in Roche’s Light Cycler PCR platform. Results: APOE4 allele frequency was 20.57% in the ADD group, 17.69% in the MCI group, and 6.67% in the control group. APOE3/3 homozygosity was the most common genotype, while the frequency of APOE4/4 homozygosity was higher in the AD group (8.60%). APOE4 carrier status was associated with higher odds for ADD and MCI (OR: 4.49, 95% CI: [1.90–10.61] and OR: 3.82, 95% CI: [1.59–9.17], respectively). Conclusion: this study examines the APOE isoforms and is the first to report a higher APOE frequency in MCI compared with healthy controls in southern Greece. Importantly, we report the occurrence of the APOE4 allele, related to ADD, as amongst the lowest globally reported, even within the nation, thus enhancing the theory of ethnicity and latitude contribution.Keywords
This publication has 81 references indexed in Scilit:
- Apolipoprotein E ε4 Prevalence in Alzheimer’s Disease Patients Varies across Global Populations: A Systematic Literature Review and Meta-AnalysisDementia and Geriatric Cognitive Disorders, 2010
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- APOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive AgingAnnual Review of Clinical Psychology, 2009
- Differential Greek and northern African migrations to Sicily are supported by genetic evidence from the Y chromosomeEuropean Journal of Human Genetics, 2008
- Correlation between Genetic and Geographic Structure in EuropeCurrent Biology, 2008
- Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene databaseNature Genetics, 2007
- Alzheimer's diseaseThe Lancet, 2006
- Apolipoprotein E 4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health StudyJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Mild Cognitive Impairment as a Clinical Entity and Treatment TargetArchives of Neurology, 2005
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993